Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA) (vol 270, pg 2531, 2023)

被引：0

作者：

Oskoui, Maryam W. ^{[1
,2
]}

Day, John ^{[3
]}

Deconinck, Nicolas S. ^{[4
,5
,6
]}

Mazzone, Elena ^{[7
,8
]}

Nascimento, Andres ^{[9
]}

Saito, Kayoko ^{[10
]}

Vuillerot, Carole ^{[11
,12
]}

Baranello, Giovanni ^{[13
,14
,15
]}

Goemans, Nathalie ^{[16
]}

Kirschner, Janbernd ^{[17
]}

Kostera-Pruszczyk, Anna ^{[18
]}

Servais, Laurent ^{[19
,20
,21
,22
]}

Papp, Gergely ^{[23
]}

Gorni, Ksenija ^{[24
]}

Kletzl, Heidemarie ^{[25
]}

Martin, Carmen ^{[26
]}

McIver, Tammy S. ^{[26
]}

Scalco, Renata ^{[27
]}

Staunton, Hannah ^{[26
]}

Yeung, Wai Yin ^{[26
]}

Fontoura, Paulo ^{[24
]}

Mercuri, Eugenio ^{[7
,8
]}

机构：

[1] McGill Univ, Dept Pediat, Montreal, PQ, Canada

[2] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada

[3] Stanford Univ, Dept Neurol, Palo Alto, CA USA

[4] UZ Gent, Neuromuscular Reference Ctr, Ghent, Belgium

[5] Univ Libre Bruxelles, Queen Fabiola Childrens Univ Hosp, Ctr Reference Malad Neuromusculaires, ULB, Brussels, Belgium

[6] Univ Libre Bruxelles, Queen Fabiola Childrens Univ Hosp, Serv Neurol Pediat, ULB, Brussels, Belgium

[7] Catholic Univ, Pediat Neurol Inst, Rome, Italy

[8] Fdn Policlin Gemelli IRCCS, Nemo Pediat, Rome, Italy

[9] Hosp St Joan de Deu, Fdn St Joan de Deu, Neuropaediat Dept, Neuromuscular Unit,CIBERER ISC III, Barcelona, Spain

[10] Tokyo Womens Med Univ, Inst Med Genet, Tokyo, Japan

[11] CHU Lyon, Hop Mere Enfant, Dept Pediat Phys Med & Rehabil, Lyon, France

[12] Univ Lyon, Neuromyogen Inst, CNRS UMR 5310 INSERM U1217, Lyon, France

[13] UCL, NIHR Great Ormond St Hosp Biomed Res Ctr, Great Ormond St Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England

[14] Great Ormond St Hosp Trust, London, England

[15] Fdn IRCCS Ist Neurol Carlo Besta, Dev Neurol Unit, Milan, Italy

[16] Univ Hosp Leuven, Neuromuscular Reference Ctr, Dept Paediat & Child Neurol, Leuven, Belgium

[17] Univ Freiburg, Fac Med, Med Ctr, Dept Neuropediat & Muscle Disorders, Freiburg, Germany

[18] Med Univ Warsaw, Dept Neurol, Warsaw, Poland

[19] Hop Armand Trousseau, I Mot, Paris, France

[20] Univ Oxford, MDUK Oxford Neuromuscular Ctr, Dept Paediat, Oxford, England

[21] Univ Hosp Liege, Ctr References Malad Neuromusculaires, Div Child Neurol, Liege, Belgium

[22] Univ Liege, Liege, Belgium

[23] F Hoffmann La Roche Ltd, Pharm Dev, Safety, Basel, Switzerland

[24] F Hoffmann La Roche Ltd, PDMA Neurosci & Rare Dis, Basel, Switzerland

[25] Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Basel, Switzerland

[26] Roche Prod Ltd, Welwyn Garden City, England

[27] F Hoffmann La Roche Ltd, Pharm Dev Neurol, Basel, Switzerland

来源：

JOURNAL OF NEUROLOGY | 2023年 / 270卷 / 5期

关键词：

D O I：

10.1007/s00415-023-11658-6

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：2547 / 2549

页数：3

共 50 条

[31] JEWELFISH: Safety, Pharmacodynamic and Exploratory Efficacy Data in Non -Na ve Patients with Spinal Muscular Atrophy (SMA) Receiving Treatment with Risdiplam
Chiriboga, Claudia A.
Bruno, Claudio
Duong, Tina
Fischer, Dirk
Kirschner, Janbernd
Mercuri, Eugenio
Gerber, Marianne
Gorni, Ksenija
Kletzl, Heidemarie
Carruthers, Imogen
Martin, Carmen
Warren, Francis
Scoto, Mariacristina
NEUROLOGY, 2022, 98 (18)
[32] FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy
Deconinck, N.
Baranello, G.
Boespflug-Tanguy, O.
Day, J.
Klein, A.
Masson, R.
Mazurkiewicz-Beldzinska, M.
Mercuri, E.
Rose, K.
Servais, L.
Vlodavets, D.
Xiong, H.
Zanoteli, E.
El-Khairi, M.
Gerber, M.
Gorni, K.
Kletzl, H.
Dodman, A.
Gaki, E.
Darras, B.
EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 279 - 279
[33] Nusinersen experience in spinal muscular atrophy type 1: two-year results of 21 patients
Tagiyev, A.
Bulut, N.
Aydin, G.
Gurbuz, I. Alemdaroglu
Eroglu, N.
Yilmaz, O.
Haliloglu, G.
Karaduman, A.
Topaloglu, H.
NEUROMUSCULAR DISORDERS, 2018, 28 : S79 - S79
[34] SUNFISH part 1: safety, tolerability, PK/PD, and exploratory efficacy data in patients with Type 2 or 3 spinal muscular atrophy (SMA)
Mercuri, E.
Baranello, G.
Kirschner, J.
Servais, L.
Goemans, N.
Pera, M. C.
Buchbjerg, J.
Yeung, W. Y.
Kletzl, H.
Gerber, M.
Czech, C.
Cleary, Y.
Gorni, K.
Khwaja, O.
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 224 - 224
[35] SUNFISH Part 1: 24-month safety and exploratory outcomes of risdiplam (RG7916) treatment in patients with Type 2 or 3 spinal muscular atrophy (SMA)
Day, J.
Baranello, G.
Boespflug-Tanguy, O.
Borell, S.
Goemans, N.
Kirschner, J.
Masson, R.
Pera, M.
Servais, L.
Fuhrer, S.
Gerber, M.
Gorni, K.
Kletzl, H.
Martin, C.
Scalco, R.
Staunton, H.
Yeung, W.
Mercuri, E.
NEUROMUSCULAR DISORDERS, 2020, 30 : S123 - S123
[36] FIREFISH Parts 1 and 2: 12-month pooled safety and efficacy outcomes of risdiplam (RG7916) in infants with Type 1 spinal muscular atrophy (SMA)
Servais, L.
Bloespflug-Tanguy, O.
Darras, B.
Day, J.
Deconinck, N.
Klein, A.
Masson, R.
Mazurkiewicz-Beldzinska, M.
Mercuri, E.
Rose, K.
Vlodavets, D.
Xiong, H.
Zanoteli, E.
Dodman, A.
El-Khairi, M.
Gerber, M.
Gorni, K.
Kletzl, H.
Scalco, R.
Baranello, G.
NEUROMUSCULAR DISORDERS, 2020, 30 : S126 - S126
[37] Risdiplam in type 2 and 3 spinal muscular atrophy: results of a cohort of adult Italian patients. A 3-year follow-up
Lucia, R.
Russo, A.
Iodice, R.
Dubbioso, R.
Tozza, S.
Esposito, G.
Zoppi, D.
NEUROMUSCULAR DISORDERS, 2024, 43
[38] Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial
Masson, Riccardo
Mazurkiewicz-Beldzinska, Maria
Rose, Kristy
Servais, Laurent
Xiong, Hui
Zanoteli, Edmar
Baranello, Giovanni
Bruno, Claudio
Day, John W.
Deconinck, Nicolas
Klein, Andrea
Mercuri, Eugenio
Vlodavets, Dmitry
Wang, Yi
Dodman, Angela
El-Khairi, Muna
Gorni, Ksenija
Jaber, Birgit
Kletzl, Heidemarie
Gaki, Eleni
Fontoura, Paulo
Darras, Basil T.
LANCET NEUROLOGY, 2022, 21 (12): : 1110 - 1119
[39] Natural History of Type 2 and 3 Spinal Muscular Atrophy (SMA): Longitudinal 2-year NatHis-SMA Study
Servais, Laurent
Seferian, Andreea Mihaela
Daron, Aurore
Pereon, Yann
Cances, Claude
Vuillerot, Carole
De Waele, Liesbeth M. H.
Laugel, Vincent
Schara, Ulrike
Gidaro, Teresa
Lilien, Charlotte
Hogrel, Jean-Yves
Baudin, Pierre-Yves
Carlier, Pierre
Fournier, Emmanuel
Lowes, Linda Pax
Gorni, Ksenija
Ly-Le Moal, Myriam
Hellbach, Nicole
Seabrook, Timothy
Czech, Christian
Hermosilla, Ricardo
Annoussamy, Melanie
NEUROLOGY, 2020, 94 (15)
[40] Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study
Annoussamy, Melanie
Seferian, Andreea M.
Daron, Aurore
Pereon, Yann
Cances, Claude
Vuillerot, Carole
De Waele, Liesbeth
Laugel, Vincent
Schara, Ulrike
Gidaro, Teresa
Lilien, Charlotte
Hogrel, Jean-Yves
Carlier, Pierre
Fournier, Emmanuel
Lowes, Linda
Gorni, Ksenija
Ly-Le Moal, Myriam
Hellbach, Nicole
Seabrook, Timothy
Czech, Christian
Hermosilla, Ricardo
Servais, Laurent
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (05): : 1165 - 1167

← 1 2 3 4 5 →